Phase I Safety Trial of Soluble Complement Receptor Type I (TP 10) in Acute Myocardial Infarction

George Perry

doi:10.1016/s0735-1097(97)85487-3

Related publications

Article2005

VALIANT (VALsartan In Acute myocardial iNfarcTion) trial

Aldo Maggioni, Gianna Fabbri

Article2006

Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

Shelby D. Reed, John J.V. McMurray, Eric J. Velazquez, Kevin A. Schulman, Robert M. Califf, Lars Køber, Aldo Maggioni, Frans Van de Werf, Harvey D. White, Rafael Díaz, Mareev VIu, Ján Murín

Article2008

High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

Rachel Anderson, Marc A. Pfeffer, Jens Jakob Thune, John J.V. McMurray, Robert M. Califf, Eric J. Velazquez, Harvey D. White, Jean L. Rouleau, Hicham Skali, Aldo Maggioni, Scott D. Solomon

Article2000

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Marc A. Pfeffer, John J.V. McMurray, Alain Leizorovicz, Aldo Maggioni, Jean‐Lucien Rouleau, Frans Van de Werf, Marc Henis, Eric Neuhart, Paul Gallo, Susan Edwards, Mary Ann Sellers, Eric J. Velazquez, Robert M. Califf

Article1997

Frequency of Family History of Acute Myocardial Infarction in Patients With Acute Myocardial Infarction

Mario Ciruzzi, Hermán Schargrodsky, Jorge Rozlosnik, Palmira Pramparo, Hernán Delmonte, Viviana Rudich, Daniel Piskorz, Eva Negri, Saúl Soifer, Carlo La Vecchia